Low levels of miR-150 in CLL patients increase BCR signaling by increasing the levels of FOXP1 and GAB1 (11), resulting in the increased invasiveness of CLL B cells. This evidence concerns the gene FOXP1 and B-cell chronic lymphocytic leukemia.